2 Mid-Cap Stocks Set to Deliver Superior Returns With or Without a Vaccine

These two TSX-listed mid-cap stocks could continue to do well with or without the vaccine.

| More on:
pharma, vaccine, coronavirus, COVID

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Investors flocked to TSX-listed tech stocks amid the peak of the pandemic to gain big from the rally in the shares of the companies that benefitted from the pandemic. However, with the vaccine on the horizon, investors are dumping tech stocks and buying shares of the companies hit hard by COVID-19. 

For instance, shares of Suncor Energy and Air Canada have soared over 38% and 39%, respectively, in one month. In comparison, shares of Real MattersAbsolute Software, and Kinaxis have decreased by over 20.5%, 16.3%, and 13.7%, respectively, during the same period. 

While the positive development over the vaccine is encouraging, it is still unclear when a vaccine could arrive, raising skepticism over the stock market’s prospect. However, a few TSX-listed mid-cap stocks could continue to do well with or without the vaccine. 

These companies witness stable demand for their products and services and have strong fundamentals that provide a solid foundation for outsized growth in the coming years. Let’s focus on two top mid-cap stocks that could deliver superior returns.

Cargojet

Cargojet (TSX:CJT) stock has consistently outperformed the broader markets and generated stellar returns irrespective of the economic situation. The air cargo company witnesses sustained demand, thanks to its robust delivery capabilities, and holds a lion’s share in the domestic air cargo segment.

Meanwhile, its high retention rate, acquisition of new customers, and network and capacity expansion, and strong demand from the e-commerce segment provides a solid foundation for outsized growth in the coming years. 

About two-thirds of Cargojet’s domestic revenues have long-term contractual arrangements with CPI-base price annual increases and guaranteed volume minimums. Meanwhile, its cost advantage over peers positions it well to expand its market share and deliver consistent growth. 

Lightspeed POS 

Lightspeed POS (TSX:LSPD)(NYSE:LSPD) is another top stock that could continue to perform well with or without the COVID-19 vaccine. While the pandemic has driven the demand for its digital products that support omnichannel payments and e-commerce, the momentum is likely to sustain even in the post-pandemic world. 

The structural shift from a traditional payments platform towards a cloud-based omnichannel platform has created a multi-year growth opportunity for Lightspeed. Meanwhile, innovation and expansion of its product suite and geographical expansion should accelerate its growth further.  

Besides the strength in its core business, Lightspeed is also likely to benefit from the strategic acquisitions. With a large addressable market and strong competitive positioning, Lightspeed remains well positioned to deliver strong returns in the coming years.  

Lightspeed stock is also looking attractive on the valuation front. Despite the massive recovery rally in its stock, it trades at an EV/sales multiple of 20.7, reflecting a discount of about 39% compared to Shopify 

Bottom line 

Cargojet and Lightspeed are all-weather stocks and could continue to deliver superior returns over the next decade. Both these companies have strong growth catalysts, including secular industry tailwinds, strong competitive positioning, and large addressable markets, which are likely to support the uptrend in their stocks. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends CARGOJET INC., Shopify, and Shopify. The Motley Fool owns shares of Lightspeed POS Inc. The Motley Fool recommends KINAXIS INC and Real Matters Inc.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »